Form 4 for HCA HCA Healthcare
Accepted 2024-05-17 00:00:00 ET · period of report 2024-05-15 · accession 0001209191-24-005662 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-17 | 2024-05-15 | HCA | Sowell Joseph A III | SVP, Chief Development Off | M - OptEx | $68.96 | +19.0K | 23.3K | +444% | +$1.31M |
| D | 2024-05-17 | 2024-05-15 | HCA | Sowell Joseph A III | SVP, Chief Development Off | F - Tax | $326.96 | -9,908 | 13.4K | -43% | -$3.24M |
| D | 2024-05-17 | 2024-05-15 | HCA | Sowell Joseph A III | SVP, Chief Development Off | M - OptEx | $0.00 | -19.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-15 | M | A | 19,000 | $68.96 | 23,275 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-15 | F | D | 9,908 | $326.96 | 13,367 | D | — | — | |
| 3 | Derivative | Stock Appreciation Right | 2024-05-15 | M | D | 19,000 | $0.00 | 0 | D | $68.96 · — to 2025-02-04 | 19,000 Common Stock | (F1) The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016. |